Furthermore, the expression of the BK receptor 1 (B1R) was assessed in the postmortem liver specimens of 27 COVID-19 individuals and compared to patients with colon cancer, with the results showing increased B1R expression levels in the hepatic tissues of patients with COVID-19 [22]. This evidence concerns the gene BDKRB1 and COVID-19.